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Background: Theranostic nanomaterials composed of fluorescent and photothermal agents can 
both image and provide a method of disease treatment in clinical oncology. For in vivo use, the 
near-infrared (NIR) window has been the focus of the majority of studies, because of greater 
light penetration due to lower absorption and scatter of biological components. Therefore, having 
both fluorescent and photothermal agents with optical properties in the NIR provides the best 
chance of improved theranostic capabilities utilizing nanotechnology.
Methods: We developed nonplasmonic multi-dye theranostic silica nanoparticles   (MDT-NPs), 
combining NIR fluorescence visualization and photothermal therapy within a single nanocon-
struct comprised of molecular components. A modified NIR fluorescent heptamethine cyanine 
dye was covalently incorporated into a mesoporous silica matrix and a hydrophobic metallo-
naphthalocyanine dye with large molar absorptivity was loaded into the pores of these fluorescent 
particles. The imaging and therapeutic capabilities of these nanoparticles were demonstrated 
in vivo using a direct tumor injection model.
Results: The fluorescent nanoparticles are bright probes (300-fold enhancement in quantum yield 
versus free dye) that have a large Stokes shift (.110 nm). Incorporation of the naphthalocyanine 
dye and exposure to NIR laser excitation results in a temperature increase of the surrounding 
environment of the MDT-NPs. Tumors injected with these NPs are easily visible with NIR 
imaging and produce significantly elevated levels of tumor necrosis (95%) upon photothermal 
ablation compared with controls, as evaluated by bioluminescence and histological analysis.
Conclusion: MDT-NPs are novel, multifunctional nanomaterials that have optical properties 
dependent upon the unique incorporation of NIR fluorescent and NIR photothermal dyes within 
a mesoporous silica platform.
Keywords: bioluminescence, in vivo imaging, mesoporous silica nanoparticles, NIR 
  fluorescence, photothermal ablation, theranostic
Introduction
A requirement for engineered theranostic nanoparticles (NPs) is the simultaneous 
ability to function as imaging contrast agents for disease localization and serve as 
mediators of disease therapy. For clinically relevant applications of these nanomaterials 
in oncology, optical components with absorption/emission in the near-infrared (NIR) 
(650–900 nm) are preferred candidates, due to their high detection sensitivity (fluo-
rescent NPs) and their ability to deliver localized photothermal therapy (plasmonic 
NPs) at deeper penetration depths, due to the low extinction coefficients of water, 
tissue, and blood in this region.1
Theranostic NPs made of optical components incorporate a diagnostic agent (eg, 
fluorescent dye) with a photothermal therapeutic treatment (eg, plasmonic material). 
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A common example of a NIR fluorescent material as 
a   diagnostic component is indocyanine green (ICG)-
encapsulated NPs.2 However, the inferior photophysical/
photochemical properties of ICG (low quantum yield [QY], 
low physiological stability, poor photostability under harsh 
synthesis conditions, and photobleaching)2 and technical 
challenges associated with incorporating it into an NP matrix 
leads to undesirable dye leaching and a lower signal-to-noise 
ratio in fluorescence imaging.
Having optical properties that are size and shape dependent, 
NIR plasmonic nanostructures are photothermal materials that 
have been widely explored for therapeutic applications.3–5 
However, a specific absorption profile may not be possible if a 
different size or shape is required for a particular application; in 
other words, these materials possess optical tunability but lack 
size/shape tunability for a given optical property. For example, 
in order to tune their plasmon resonances to the NIR, the size 
and geometry of gold NPs must be altered.  This change in size 
and shape may affect their functionalization, uptake, transport, 
and targeting capabilities.
Combining plasmonic materials with a fluorescent com-
ponent into a single theranostic nanoconstruct has   numerous 
challenges and its use has remained limited thus far.6,7 
The aforementioned limitations of fluorescent NPs can be 
further exacerbated by fluorescence quenching, due to the 
  fluorophore’s close proximity to the plasmonic component.8 
Consequently, realization of optical image-guided therapy 
using theranostic NPs continues to be an area of active 
research.
Herein, we describe a simple approach for combining 
NIR fluorescent in vivo imaging and photothermal ablation 
therapy using mesoporous silica NPs as a carrier vehicle for 
multiple dyes. Mesoporous silica NPs have been explored 
to a great extent as imaging agents, drug carriers, and thera-
nostic agents in various biological applications, most notably 
in oncology.9,10 They are a common platform for theranos-
tic nanomaterials, as the silica matrix can hold one agent 
while a different agent is introduced within the pores. Our 
multi-dye theranostic nanoparticles (MDT-NPs) are hybrid 
organic–inorganic nanoconstructs that employ multiple 
organic dyes for simultaneous imaging and cancer therapy. 
A   mechanically robust scaffold of mesoporous silica NPs was 
selected for the synthesis of these hybrid NPs. A silica matrix 
is preferred due to its biocompatibility, optical transparency, 
and water dispersibility. In addition, Lee et al have found that 
mesoporous silica NPs exhibit less cytotoxicity and reduced 
inflammatory response and apoptosis than colloidal silica 
NPs of the same size and shape.11
Materials and methods
Reagents
IR780  iodide  (IR780),  12-aminododecanoic  acid, 
3-  aminopropyltriethoxysilane (APTES), 2-(N-morpholino)
ethanesulfonic acid (MES), cetyltrimethylammonium bro-
mide (C16TAB), silicon 2,3-naphthalocyanine dihydroxide 
  (Si-naphthalocyanine), zinc 2,11,20,29-tetra-tert-butyl-2, 
3-naphthalocyanine, iron (II) 1,2,3,4,8,9,10,11,15,16,17,   
18,22,23,24,25-hexadecachloro-29H,31H-  phthalocyanine, 
manganese (III) phthalocyanine chloride, and ICG 
were purchased from Sigma-Aldrich (St Louis, MO). 
  Anhydrous N, N-  dimethylformamide (DMF), triethylamine, 
N-  hydroxysuccinimide (NHS), N-(3-Dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC), tetraethyl 
orthosilicate (TEOS), sodium hydroxide (NaOH), methanol, 
calcium chloride (CaCl2), and chloroform (CHCl3) were pur-
chased from Fisher Scientific (Pittsburgh, PA). Luciferin was 
purchased from Caliper Life Sciences (Hopkinton, MA).
APTES-conjugated NIR fluorescent dye
The NIR dye IR780 was chemically modified to include a 
silane group that covalently links the dye in the silica matrix 
(Figure S1). IR780 (300 mg) was dissolved in 10 mL of anhy-
drous DMF in a 100 mL, round-bottom flask.   Triethylamine 
(200 µL) and 12-aminododecanoic acid (254 mg) were added 
and the solution was heated for 3 hours at 85°C under a 
nitrogen environment. The green solution turned blue upon 
completion of the meso-chlorine replacement reaction. The 
carboxylic acid group of the resulting acid-conjugated dye 
was coupled with the primary amine of APTES, using car-
bodiimide coupling. Briefly, NHS (20 mg) was dissolved in 
1 mL of acid-conjugated dye solution in DMF (30 mg/mL), 
after which EDC (60 mg) dissolved in 400 µL of 25 mM 
MES buffer, pH 6.5, was added to the dye solution. After 
15 minutes of stirring, 50 µL of APTES was added to this 
solution, and the reaction proceeded for ∼2 hours.
Near-infrared fluorescence (NIRF) 
mesoporous silica NPs
Mesoporous silica NPs were synthesized by condensa-
tion of TEOS in the presence of C16TAB as the structure-
directing template, under basic pH conditions at an elevated 
  temperature. Briefly, 0.5 g of C16TAB and 1.75 mL of 2 M 
NaOH were added to 240 mL of Nanopure® water   (resistivity 
18.2 MΩ-cm). This surfactant solution was heated to 80°C. 
After the temperature stabilized, 2.5 mL of TEOS was added 
dropwise to this solution. After 2–3 minutes, the transparent 
solution turned translucent, due to the nucleation of silica NPs. 
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At this time, the desired amount of APTES-conjugated 
  fluorescent dye (100–2000 µL) was added. The particle sus-
pension was allowed to stir for 3 hours at 80°C. To remove the 
surfactant, ∼800 mg particles were centrifuged (20 minutes, 
7000 g) and redispersed in 200 mL of a 3% methanolic solu-
tion of CaCl2 then the suspension was refluxed for 4 hours at 
60°C. The NPs were centrifuged again (20 minutes, 7000 g) 
and redispersed in methanol. This step was repeated three 
times, to remove the surfactant completely from the pores. 
Removal of surfactant was confirmed by a cell membrane 
permeability assay (Figure S2). Finally, the particles were 
dispersed in Nanopure water for further experiments.
Incorporation of Si-naphthalocyanine 
heating dye
NIRF mesoporous silica NPs (100 mg) were centrifuged 
and dispersed in 80 mL chloroform. Si-naphthalocyanine 
dye (80 mg) in chloroform (1 mg mL−1) was added to the 
silica NP dispersion. The dispersion was refluxed overnight 
at 60°C, to load the dye into the pores of the NPs then the 
particles were centrifuged and redispersed in water for further 
experiments. The absorption spectrum of the supernatant was 
used to estimate the amount of dye that was adsorbed into 
the pores of the NPs.
NP characterization
Absorption and fluorescence spectra were obtained with 
a PerkinElmer LAMBDA 800 UV/VIS spectrometer 
(Waltham, MA) and a HORIBA Jobin Yvon NanoLog® 
fluorometer (Edison, NJ), respectively. Fluorescence QYs 
were measured using an integrating sphere to mitigate light 
scatter from the NPs, and the fluorescence and absorption of 
the sample were compared with the solvent blank. Scanning 
electron microscopy was performed with a JEOL JSM-6335F 
field emission scanning electron microscope (Tokyo, Japan) 
operating at 15 keV; transmission electron microscopy was 
performed with a JEOL 2010F transmission electron micro-
scope operating at 200 keV . X-ray diffraction was obtained 
with a Philips APD 3720 X-ray diffractometer (Amsterdam, 
The Netherlands) using Cu Kα radiation.
Temperature change measurements
A fiber-coupled continuous wave laser source (BWF2-785-5-
400-0.22-SMA; B&W TEK Inc, Newark, DE) with a center 
wavelength of 785 nm was used. The output power of the laser 
was kept constant at 500 mW (450 mA laser diode current) 
in all experiments. An optical fiber sample cell was used to 
transfer the NIR laser radiation from the laser source to the 
sample cell. The end of the optical fiber was connected to a 
collimating lens and positioned 3 cm above the liquid level 
in the sample cell (Fisherbrand 1.5 mL methacrylate cuvette; 
Fisher Scientific). The sample cell was filled with a 1 mL 
aqueous suspension of mesoporous NPs. A thermocouple 
was fixed away from the laser path in the sample cell for 
temperature measurement.
Experimental tumor model
The 4T1 murine mammary tumor cell line expressing the 
firefly luciferase enzyme (Tufts University, Boston, MA) was 
orthotopically implanted (1 × 106 cells) into female BALB/c 
mice (Charles River Laboratories, Wilmington, MA).12 On 
post-  implantation day 8, the mice were imaged via fluorescence 
(710 nm excitation/820 nm emission) and bioluminescence 
(620 nm emission, image obtained 10 minutes after intraperi-
toneal injection of luciferin [100 µL, 15 mg mL−1]) using an 
IVIS Spectrum (Caliper Life Sciences). The mice were ran-
domly distributed to one of three groups – MDT-NP/+ablation, 
MDT-NP/-ablation, and saline/+ablation – and then underwent 
intratumoral injection of MDT-NPs (1 mg mL−1, 15 µL) 
or 0.9% NaCl (15 µL). Fluorescent imaging was obtained 
on all mice after the injection. The mice in the particular 
experimental groups then underwent photothermal ablative 
therapy (continuous wave laser, 785 nm, 637 mW cm−2, 
5 minutes duration, 1.5 cm source–tumor distance), after 
which fluorescent imaging was obtained. All the mice then 
underwent bioluminescent imaging. On post-ablation day 1, 
the mice underwent fluorescent/bioluminescent imaging, after 
which they were euthanized. The tumors were harvested and 
preserved in 10% neutral buffered formalin for histological 
analysis. Histological tumor analysis was performed in a 
blinded fashion and quantified as percent necrosis by a board-
certified pathologist (JAK). Region of interest quantification 
of fluorescent and bioluminescent signals was performed at 
all imaging points with Living Image 3.2 software (Caliper 
Life Sciences). Approval for the animal studies was obtained 
from the University of Florida Institutional Animal Care and 
Use Committee and the experiments were all conducted in 
accordance with their policies.
Results and discussion
A reaction scheme for the synthesis of MDT-NPs is presented 
in Figure 1. First, a NIRF heptamethine cyanine dye was 
covalently incorporated within the silica framework during 
the synthesis of the mesoporous NPs, which prevents its leak-
age and enhances its photophysical properties by decreasing 
dye aggregation. The resulting NIRF NPs can be imaged with 
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high signal-to-noise ratio, because their large Stokes shift 
(.110 nm) mitigates self-quenching and allows collection of 
the complete emission spectrum. Second, a NIR photothermal 
Si-naphthalocyanine dye was physically encapsulated in the 
cylindrical pores of the NIRF mesoporous silica NPs. The 
development of MDT-NPs from molecular-level components 
allows for the possibility of changing the size and shape of 
NPs without altering their optical properties. Different optical 
properties could be obtained simply by selecting dyes with 
the desired characteristics. Application of these theranostic 
MDT-NPs for bioimaging and therapy in a murine model 
of breast cancer is demonstrated. In order to overcome the 
aforementioned limitations of cyanine dyes, such as ICG, 
various modifications of these dyes have been developed 
to improve dye stability for NIR imaging. For example, 
heptamethine cyanine dyes have been modified by introduc-
ing a chlorocyclohexenyl ring in the methine chain, which 
improves photostability and fluorescence QY and provides 
a site for further chemical modification.13
In the present work, one of these heptamethine cyanine 
dyes (IR780) was modified with an aminoalkylcarboxylic 
acid; introducing an aminoalkyl group at the central position 
results in a relatively stronger fluorescent dye with a large 
Stokes shift (.110 nm) compared with IR780 itself. Due to 
this large Stokes shift, fluorescence resonance energy transfer 
among the dye molecules would be negligible, thus making 
encapsulation inside a solid matrix more viable while retain-
ing high luminescence. This modified dye was further conju-
gated with an aminosilane, using carbodiimide chemistry in 
order to incorporate it covalently into the silica NPs   during 
the hydrolysis and condensation of the silica precursor. 
  Incorporating the dye molecules in surfactant micelles pro-
tects the dye from the harsh chemical environment commonly 
used in silica NP syntheses, where the NIR dye can lose its 
fluorescence properties. In addition, the micelles mitigate 
the quenching of fluorescence that often occurs because of 
dye aggregation in aqueous media during its incorporation 
within the silica matrix. A supramolecular self-assembly of 
mixed micelles composed of C16TAB and modified IR780-
APTES conjugate forms lyotropic liquid–crystalline phases 
that serve as the template for the formation of dye-doped, 
mesostructured silica NPs. Because of the well-dispersed (or 
evenly distributed) dye molecules in the silica matrix, the 
resulting NPs possess high photoluminescence and enhanced 
QY (300-fold increase over free dye), even in aqueous media 
(Figure S3). The shapes of the absorbance and fluorescence 
spectra and the large Stokes shift of the dye remain intact after 
its encapsulation in the particles. Normalized absorbance 
and emission spectra of the modified heptamethine dye in 
the free state and upon its encapsulation in mesoporous NPs 
are presented in Figure 2.
The QY of the heptamethine dye in the silica matrix was 
found to be 3.3-fold higher than the reported QY of ICG dye in 
a silica matrix (Figure S3). Increasing the amount of modified 
IR780 dye inside the silica matrix resulted in lower fluores-
cence QYs, most likely due to dye aggregation; however, the 
absorption cross-section and molar absorptivity of the NPs 
increased. The photoluminescence of these particles was opti-
mized by varying the amount of dye present inside the silica 
matrix. The average size of these NIRF NPs was 105 ± 16 nm, 
as measured by scanning electron microscopy and transmis-
sion electron microscopy (Figure 3), with an average pore 
center-to-center distance of 3.6 nm (Figure S4).
To impart photothermal properties to NIRF NPs, an 
organic photothermal sensitizer can be incorporated within 
the pores of mesoporous NIRF NPs. The ideal candidate 
for this purpose should have low fluorescence QY and 
low photochemical reactivity for it to have good photo-
thermal properties. After photoexcitation, these molecular 
absorbers are expected to increase the local temperature 
significantly enough to cause irreversible photothermal 
damage to the surrounding tumor cells. Naphthalocyanine 
dyes are particularly suited for this purpose, as they have 
an intense absorption band (ε ≈ 2 × 105 M−1 cm−1) in the 
NIR region, are nonfluorescent (QY , 0.001), and lack 
appreciable biochemical   activity. Many naphthalocyanine 
1. TEOS, IR780-APTES
pH 10, 80 °C, 3 h
Si-naphthalocyanine
CHCI3, Reflux, 12 h
2. CaCl2, MeOH
60 °C, 4 h
Figure 1 Reaction scheme for the synthesis of MDT-NPs. (Left) Hexagonal array of C16TAB cylindrical micelles. (Center) NIRF silica nanoparticles formed by co-condensation 
of modified IR780-APTES dye conjugate with TEOS. (Right) MDT-NPs synthesized by encapsulation of Si-naphthalocyanine dye within the pores of mesoporous NIRF particles.
Abbreviations: APTES, 3-aminopropyltriethoxysilane; C16TAB, cetyltrimethylammonium bromide; DMF, N, N-dimethylformamide; IR780, IR780 iodide; MDT-NPs, multi-dye 
theranostic silica nanoparticles; NIRF, near-infrared fluorescence; TEOS, tetraethyl orthosilicate.
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Figure  2  Normalized  spectra:  (A)  IR780  dye  before  and  after  modification: 
(i) absorbance (IR780); (ii) fluorescence (IR780); (iii) absorbance (modified IR780); 
(iv) fluorescence (modified IR780). (B) Absorbance (iii) and fluorescence (iv) of 
modified IR780 dye after encapsulation in mesoporous silica nanoparticles.
Notes: Absorbance (i) and fluorescence (ii) of modified IR780 is also shown for 
comparison.
Figure 3 (A) Scanning electron microscopy and (B) transmission electron microscopy images of multi-dye theranostic silica nanoparticles.
dyes are reported to be   nonlinear optical materials that 
undergo triplet-state absorption at high laser fluencies, 
thereby enhancing light absorption-induced effects.14–17   
At low light fluencies, such as those used for imaging, pho-
toluminescence can be maximized due to reduced absorption 
from naphthalocyanine dyes.  Furthermore, these materials 
are considered to be   third-generation photodynamic agents 
and are actively being pursued for clinical applications:18 
metallo-naphthalocyanine dyes have been shown to destroy 
cancer cells with a photothermal therapy effect,19,20 and 
they have been developed to act as photodynamic pho-
tosensitizers for cancer therapy by generation of singlet 
oxygen.21–23 This photodynamic effect can be synergistic 
with the proposed photothermal effect. Upon heating, and 
in the presence of a lipid-rich physiological environment, 
naphthalocyanine dye is believed to liberate itself from the 
particle and become regionally disseminated. During this 
process, the dye maintains some of its photothermal activ-
ity and may become more photodynamic in nature, similar 
to molecular sensitizers. As with the heptamethine cyanine 
dyes, incorporation of naphthalocyanine materials within a 
silica nanostructure was anticipated to provide the desired 
localized optical absorption properties for   photothermal/
photodynamic effects, without the complications that are 
often experienced with free dye materials. Upon 2 minutes 
exposure to laser irradiation (637 mW cm−2), all metallo-(na)
phthalocyanine dyes investigated here (Si, Zn, Fe, Mn) either 
degraded or formed aggregates in aqueous media, due to their 
hydrophobic aromatic structure (Table S1). These aggregates 
can be up to several microns in size and are less effective 
for light absorption. Once encapsulated inside the particles, 
the photostability of the dye molecules increases drastically. 
Even after 5 minutes of 637 mW cm−2 laser light exposure, a 
maximum of only 5% decrease in the optical density of the 
NP suspension was observed.
In the present investigation, a Si-naphthalocyanine dye 
was loaded into the pores of NIRF mesoporous silica NPs by 
exposing them to a concentrated solution of dye that readily 
adsorbs within the pore structure. By using   chloroform, 
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there is near refractive index matching between the dye 
solvent and the silica, which reduces London–van der Waal 
interactions and, therefore, dye–silica interactions, and 
promotes internal incorporation due to the dye concentration 
gradient.   Incorporation of dye is confirmed by numerous 
observations, including: the NPs are still dispersible in water, 
despite the presence of the hydrophobic dye;   fluorescence res-
onance energy transfer (which occurs at distances of ∼5 nm) 
between the two dyes causes fluorescence quenching, indicat-
ing that the Si-naphthalocyanine dye is in close proximity to 
the fluorescent dye, which is incorporated within the silica 
matrix; and there is a broad peak in the NIR region of the 
electronic spectrum after extensive washing.
With an increased amount of Si-naphthalocyanine dye, 
the absorbance of the NPs increased, but the fluorescence 
intensity decreased (Figure 4A and B), because emitted 
photons from the NIR fluorescent dye were absorbed by 
  Si-naphthalocyanine dye molecules; there is overlap between 
the fluorescence of the modified heptamethine cyanine 
dye and the absorption of the Si-naphthalocyanine dye. 
(See UV-vis absorption spectrum of Si-naphthalocyanine 
dye, Figure S5.) Therefore, the ratio of fluorescent heptam-
ethine cyanine dye to Si-naphthalocyanine dye within the 
mesoporous silica NPs was optimized (1:9 molar ratio) for the 
combined application of optical image-guided photothermal 
therapy, with a final fluorescent dye loading of 1.2% and a 
Si-naphthalocyanine dye loading of 11.1%, by weight.
The photothermal properties of MDT-NPs were demon-
strated by measuring the temperature increase of a NP suspen-
sion (1 mL) upon irradiation with a NIR laser source (785 nm, 
637 mW cm−2, spot size [diameter] = 1 cm). Figure 4C shows 
the increase in temperature of aqueous MDT-NP suspensions 
of different concentrations. After 5 minutes of irradiation 
time, a temperature change of 18°C (±1.5°C) was measured 
for particles (1 mg mL−1) with 11% Si-naphthalocyanine dye 
(w/w) loading. Upon further increase of irradiation time, the 
suspension temperature did not change significantly (data 
not shown). There was no significant temperature change 
observed when Nanopure water alone was irradiated with the 
same laser source for the same duration of time.
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Figure 4 (A) Change in extinction of MDT-NPs upon increasing the amount of heating dye (Si-naphthalocyanine) encapsulated inside NIRF mesoporous silica NPs: 
(i) no Si-dye; (ii) 7.4% Si-dye; (iii) 11.1% Si-dye; (iv) 14.5% Si-dye. (B) Change in fluorescence and heating properties of MDT-NPs upon increasing the amount of Si-dye 
encapsulated inside NIRF mesoporous silica NPs. (C) Change in temperature of MDT-NP suspension in water when exposed to 637 mW cm−2 laser irradiation for 5 minutes: 
(i) [NP] = 0.3 mg mL−1, no Si-dye; (ii) [NP] = 0.3 mg mL−1, 11.1% Si-dye; (iii) [NP] = 1.0 mg mL−1, 11.1% Si-dye. (D) Release of dye as a percentage of initial dye loading (11.1%) 
in different particle suspensions: water, 4T1 cell media, lecithin (50 mM), C16TAB (100 mM).
Abbreviations: C16TAB, cetyltrimethylammonium bromide; MDT-NPs, multi-dye theranostic silica nanoparticles; NIRF, near-infrared fluorescence; NP, nanoparticle.
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Due to the highly hydrophobic nature of the dye, a slight 
release in a media that can solubilize hydrophobic species 
is observed (Figure 4D). A slightly higher release may be 
expected in a biological environment, due to the presence of 
additional lipophilic species (eg, phospholipids, proteins, and 
serum), which can solubilize hydrophobic moieties.
In vivo application of MDT-NPs for image-guided 
therapy was demonstrated with an orthotopic murine mam-
mary tumor model. This 4T1 tumor model was developed to 
provide immediate feedback to the photothermal therapeutic 
efficiency through in vivo imaging of bioluminescence, 
which is indicative of viable tumor cells. After intratumoral 
injection of MDT-NPs (1 mg mL−1, 15 µL), the tumor was 
irradiated with the same low-power NIR laser source for 
5 minutes. Figure 5A, B, D, and E present the fluorescence 
and bioluminescence images of tumor-bearing mice before 
and after the photothermal therapy. A decrease of ∼18% was 
observed in the fluorescence signal after laser irradiation. 
This decrease in fluorescence signal could be due to partial 
photobleaching of dye or slight particle redistribution dur-
ing and after the tumor ablation. However, even one day 
after ablation, the fluorescence intensity remained ∼600% 
higher than the background signal (Figure 5F). A decrease 
in bioluminescence signal was calculated to assess tumor 
viability. A percentage decrease of up to 95% was observed 
in mice that were irradiated with the NIR laser after intra-
tumoral injection of particles (Figure 5C). Minimal effects 
on bioluminescence were observed for control experiments 
(saline/+ablation and MDT-NPs/-ablation).
The exact mechanism of cell death in vivo is not known, 
although there is likely a contribution from the photothermal 
effect. Histologically, a congruent pattern was observed: 
saline/+ablation experiments resulted in tumor sections that 
were visibly viable, while MDT-NPs/+ablation showed 
significant areas of necrosis (Figure S6).
Conclusion
In summary, we have developed novel, hybrid organic–
inorganic MDT nanoconstructs by integrating multiple 
dyes within mesoporous silica NPs. First, a NIR heptam-
ethine cyanine fluorescent dye was modified to enable its 
covalent incorporation into a mesoporous silica matrix. The 
photoluminescence of these NIRF NPs was optimized by 
minimizing the aggregation of dye molecules during their 
covalent integration. Second, a nonfluorescent metallo-
naphthalocyanine dye was incorporated within the pores of 
these particles in order to make them photothermal agents 
for therapeutic   applications. Destruction of tumor cells using 
a semi-quantitative bioluminescence analysis of live mice 
agreed well with a histological analysis of tumor   necrosis. 
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Figure 5 Bioluminescence (A and B) and fluorescence (D and E) images of mice before (A and D) and after (B and E) photothermal ablation using a NIR laser 
(785 nm, 637 mW cm−2, 5 minutes). All mice shown were treated with MDT-NPs/+ablation, and three were included to demonstrate reproducibility. Significant decrease in 
bioluminescence and little change in fluorescence signal intensity were observed after ablation. Change in (C) bioluminescence signal and (F) fluorescence before and after 
tumor ablation measured for saline/+ablation (left), MDT-NPs/-ablation (middle), and MDT-NPs/+ablation (right) at different time points. Y-axis represents percentage change 
from background signal that was measured prior to particle injection.
Note: *No fluorescence measured because no photoablation was performed.
Abbreviations: MDT-NPs, multi-dye theranostic silica nanoparticles; NIR, near-infrared; NIRF, near-infrared fluorescence; ROI, region of interest.
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In addition, the porous structure of these NPs enabled 
  multiple functionalities, such as in vivo, multimodal imag-
ing or site-specific photogated release of hydrophobic drug 
  molecules using a NIR optical source. Based on a mesoporous 
silica platform, MDT-NPs can be personalized for a desired 
application, as individual components of this system can be 
tailored to obtain specific characteristics. Parameters that can 
be changed include the optical properties of the fluorescent 
and photothermal dye components, particle size, particle 
shape, pore size, and surface functionalization.
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Figure S1 Reaction scheme for the synthesis of modified NIR fluorescent IR780 dye. Synthetic procedures are described in Materials and methods.
Abbreviations: APTES, 3-aminopropyltriethoxysilane; IR780, IR780 iodide; NIR, near-infrared.
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Figure S2 Effect of MDT-NPs on MDA-MDB-231 cells. 
Notes: The MDT-NPs in water were incubated with MDA-MDB-231 breast epithelial cancer cells in culture and were demonstrated to be nontoxic by the lactate 
dehydrogenase membrane permeability assay following 24 hours exposure to NP concentrations up to 1 mg mL−1. These results support the complete removal of the C16TAB 
surfactant from the mesoporous NP pores.
Abbreviations: C16TAB, cetyltrimethylammonium bromide; MDT-NPs, multi-dye theranostic silica nanoparticles; NP, nanoparticle.
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Figure S3 Quantum yield (QY) of IR780 dye increases upon its encapsulation in a mesoporous matrix. 
Notes: A maximum enhancement of 283-fold was observed when compared to free IR780 dye in water. The maximum QY of encapsulated IR780 also was compared with 
the QY of ICG in free state and encapsulated state (QY values for ICG were obtained from the literature).
Abbreviations: ICG, indocyanine green; IR780, IR780 iodide; qy, quantum yield.
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Figure S4 X-ray diffractometer pattern of near-infrared fluorescence mesoporous silica nanoparticles (x-axis: angle 2θ (degree), y-axis: intensity [CPS]). 
Note: The peak represents a pore center-to-center distance of 3.6 nm, calculated using Bragg’s equation.
Abbreviation: CPS, counts per second.
Table S1 Effect of laser irradiation on different metallo-(na)phthalocyanine dyes in chloroform. All dyes were exposed to continuous 
laser excitation (785 nm, 637 mW cm−2) for 2 minutes
Dye Conc (mg/mL) Initial OD Final OD % change
Si 0.13 1 0.05 (±0.02) 95
Zn 0.01 1 0.06 (±0.02) 94
Fe 0.03 1 0.06 (±0.01) 95
Mn 0.08 1 0.05 (±0.01) 96
Notes:  Si:  silicon  2,3-naphthalocyanine  dihydroxide  (Si-naphthalocyanine);  Zn:  2,11,20,29-tetra-tert-butyl-2,3-naphthalocyanine;  Fe:  iron  (II)  1,2,3,4,8,9,10,11,15, 
16,17,18,22,23,24,25-hexadecachloro-29H,31H-phthalocyanine; Mn: manganese (III) phthalocyanine chloride.
Abbreviations: Conc, concentration; OD, optical density.
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Figure S6 Histological analysis of tumor sections: (A) saline/+ablation and (B) multi-dye theranostic silica nanoparticles (MDT-NPs)/+ablation stained with hematoxylin and 
eosin demonstrate areas of viability and necrosis, respectively. (C) Histogram shows significantly more necrosis in tumors irradiated with laser in presence of MDT-NPs, as 
determined by a board-certified pathologist (JAK). (D) Confocal microscope image (10× magnification) of a representative tissue section (stained using CellMaskTM Orange) 
containing MDT-NPs (shown by arrow).
In vivo experiments: histological analysis
Figure S6A  shows  a  viable  tumor  nodule  for  the   
saline/+ablation experiment, while Figure S6B demon-
strates areas of necrosis, hemorrhage, and edema caused 
by localized heat generation of the MDT-NPs/+ablation 
set. In addition to in vivo imaging, MDT-NPs have the 
ability to be imaged in the visible region using confocal 
microscopy. With their broad and well- separated absorp-
tion and emission spectra, additional in vitro fluores-
cence assays are possible, such as flow cytometry for 
particle uptake studies and ex vivo histopathological 
analyses.
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Figure S5 UV-vis absorbance spectrum of silicon 2,3-naphthalocyanine dihydroxide in dimethylformamide.
Absorbance of Si-naphthalocyanine dye
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